Abbott Recalls Synthroid Tablets Due to Incorrect Strength Labeling
Abbott Laboratories is recalling specific lots of Synthroid (levothyroxine sodium) tablets because bottles labeled as 150 mcg actually contained 75 mcg tablets.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves situations where use may cause temporary or medically reversible health consequences. The hazard is a labeling error resulting in incorrect dosage, which fits the criteria for moderate severity without reported injuries or fatalities.
Plain-English summary
Abbott Laboratories is voluntarily recalling 28,524 bottles of Synthroid (levothyroxine sodium) tablets. The recall involves 150 mcg (0.15 mg) tablets, 90 tablets per bottle, with NDC 0074-7069-90. The specific lot number is 18262A8, and the expiration date is 09/13.
The recall was initiated due to a labeling error regarding the declared strength. The product was labeled to contain 150 mcg tablets, but the bottles actually contained 75 mcg tablets. This discrepancy means patients may have received a lower dose of medication than prescribed.
The affected product was distributed nationwide in the United States and in Puerto Rico. Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above. If the product matches the recall description, it should be returned to the pharmacy or point of purchase for a refund or replacement.
The recalled product
- Product
- SYNTHROID (LEVOTHYROXINE SODIUM)
- Brand
- SYNTHROID
- Manufacturer
- Abbott Laboratories
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- LOT # 18262A8 Exp. 09/13
UPCs (10)
- 0300747149902
- 0300747068197
- 0300744341194
- 0300745182192
- 0300747070190
- 0300747069903
- 0300749296192
- 0300743727906
- 0300747148905
- 0300746624905
Distribution
Related recalls
Same brand · SYNTHROID
- HighSynthroid Levothyroxine Tablets Recalled for Incorrect Barcode Labeling
FDA (Drugs) · 2023-11-15
- ModerateAbbott Recalls Synthroid Tablets Due to Container Wall Defect
FDA (Drugs) · 2012-10-03
- ModerateAbbott Recalls Synthroid Tablets Due to Defective Bottle Bottoms
FDA (Drugs) · 2012-10-03
- ModerateAbbott Recalls Synthroid Tablets Due to Defective Bottle Bottoms
FDA (Drugs) · 2012-10-03
Same manufacturer · Abbott Laboratories
See all →- HighChemistry analyzer control modules recalled over software that may give erroneous results
FDA (Devices) · 2025-12-24
- HighHematology analyzers recalled because saturation flags may not be applied
FDA (Devices) · 2025-11-19
- HighCELL-DYN Ruby hematology analyzer system expiration date validation
FDA (Devices) · 2025-04-30
- HighCELL-DYN Ruby Hematology Analyzer Expiration Date Software Defect
FDA (Devices) · 2025-04-30
- HighCELL-DYN Ruby hematology analyzer expiration date software defect
FDA (Devices) · 2025-04-30
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02